Conventionally fractionated large volume head and neck re-irradiation using multileaf collimator-based robotic technique: A feasibility study-Reference-Cited by-同舟云学术

Conventionally fractionated large volume head and neck re-irradiation using multileaf collimator-based robotic technique: A feasibility study

Published:2020-09 Issue: Volume:24 Page:102-110
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Bahig Houda,Wang Catherine,Ping Ng Sweet,Phan Jack

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference41 articles.

1. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer;Forastiere;New England J Medicine,2003

2. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial;Overgaard;Lancet (London, England).,2003

3. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience;Cooper;Int J Radiat Oncol Biol Phys,1989

4. Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx;Lin;Head Neck,2005

5. Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy;Bachar;European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology -Head and Neck Surgery.,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical application of a GPU-accelerated monte carlo dose verification for cyberknife M6 with Iris collimator;Radiation Oncology;2024-07-02

2. Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria;International Journal of Radiation Oncology*Biology*Physics;2022-07